AUS
NZ
UK
CA
USA
IND
Healt
Next Science Limited to raise $35 Million via IPO – A Quick Look
March 18, 2019 01:40 PM AEDT| By Team Kalkine MediaAustralia-based medical technology company, Next Science Limited (ASX Proposed: NXS) is all set to raise A$35 million via IPO and list on ASX in the next month. The company has already launched its offer on 15 March 2019 in which it has invited its i...
5 Small Cap Healthcare Stocks - KZA, TLX, BNO, NAN And IMU
March 17, 2019 10:15 AM AEDT| By Team Kalkine MediaKazia Therapeutics Ltd (ASX: KZA) Kazia Therapeutics Ltd (ASX: KZA), a biotechnology company that operates in the arena of oncology (cancer), for the first half of FY 19 has reported 56.5% decline in the operating revenue to $28,831. The company for...
3 Healthcare Stocks - RHC, RMD And SHL
March 16, 2019 06:13 PM AEDT| By Team Kalkine MediaRamsay Healthcare Limited (ASX: RHC) Ramsay Healthcare Limited (ASX: RHC) has recently presented its Ramsay Health Care UK business prospect in the investor day program and highlighted about 1HFY19 activity and its growth strategy. According to the...
Zoono Group’s Share Surge Over 40% Post Agreement With Midas Pharma Announcement
March 15, 2019 07:32 PM AEDT| By Team Kalkine MediaZoono Group Limited (ASX: ZNO) today announced that it has entered into an agreement with Midas Pharma GmbH in Ingelheim, Germany. The agreement aims to bring both parties together for sales and distribution in the EU and selected global markets. Mi...
Recce Pharmaceuticals Reports Patent For Its Antibiotics
March 15, 2019 07:09 PM AEDT| By Team Kalkine MediaRecce Pharmaceuticals Limited (ASX: RCE) is first in developing and commercialisation of a new class of synthetic antibiotics. It has a broad range of activity designed to address the urgent global health problem of antibiotic-resistant superbugs. It...
Why BARD1 Life Sciences Looks Lucrative To Investors?
March 15, 2019 06:42 PM AEDT| By Team Kalkine MediaBiotechnology pioneer, BARD1 Life Sciences Limited (ASX: BD1) has the potential to diagnose lung and ovarian cancers at an early stage. The company, committed to transforming the early detection and prevention of cancer, has built a proprietary techn...
dorsaVi Ltd Announces Operational Changes To Reduce Its Expenses And Optimize Cash Reserve
March 15, 2019 03:27 PM AEDT| By Team Kalkine MediaMedical technology company, dorsaVi Ltd (ASX: DVL) is planning to make some operational changes to reduce its operating costs, build revenue and sales capability, and optimize cash reserves. In an announcement made on 15 March 2019, the company has...
1st Group Limited Inked Strategic Pilot Agreement With Medibank
March 15, 2019 03:09 PM AEDT| By Team Kalkine Media1st Group Limited (ASX: 1ST) is into digital health group, building the leading health services portal of Australia, MyHealth1st.com.auâ, Australiaâs online pet service portal âPetYeti.com.auâ and corporate and...
Pharmaust Limited’s Shares Jumped Over 9.3% On ASX After Announcement Of Positive Results From Phase 1 Trial
March 14, 2019 10:43 PM AEDT| By Team Kalkine MediaPharmaust Limited (ASX: PAA) is into its clinical-stage. The company is into developing targeted cancer therapeutics for human as well as animals. It is specialised in using its marketed drugs for a different purpose, which lowers the risks and costs...
OptiScanReleases Investor Presentation: Stock Surged Over 2%
March 14, 2019 09:57 PM AEDT| By Team Kalkine MediaOptiScan Imaging Limited (ASX: OIL) is into the research and development of a High Magnification Endoscope for clinical diagnosis and research; and the continuation of sales of the research grade benchtop confocal microscope system within Australia....
Australian Pharmaceutical Releases Market Update on API-Sigma Merger Proposal
March 14, 2019 07:37 PM AEDT| By Team Kalkine MediaAustralian Pharmaceutical Industries Limited (ASX: API) has acknowledged the announcement made by Sigma Healthcare rejecting merger proposal on a non-binding indicative offer made by API. The offer was valued at a premium of 41.8% over the undisturbe...
Phylogica Limited Announces A Collaboration Agreement With Ramot
March 14, 2019 05:13 PM AEDT| By Team Kalkine MediaPhylogica Limited (ASX: PYC) is a biopharmaceutical company that utilises proprietary drug discovery technologies to discover and develop novel peptide therapeutics. The company, today on 14 March 2019, announced that it has entered into a Research...
Imugene Reports Dosing Of First Patient In The HER-Vaxx Cancer Vaccine Phase 2 Study: Shares Rose Over 5%
March 14, 2019 03:33 PM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU) is into the operations of immuno-oncology. It is in its clinical stage and is into the development of a range of new and novel immunotherapies which helps to activate the immune system of cancer patients to treat and eradic...
HomeStay commenced live trial of MyDay and Carers Companion app with St John of God Health Care
March 14, 2019 02:56 PM AEDT| By Team Kalkine MediaHomeStay Care Limited (ASX: HSC) is in a unique business of designing and developing a scalable healthcare technology platform called the HomeStay Internet of Things (IoT) Platform which is intended to protect and take care of elderly people. The tec...
Medlab Clinical announced strong outcomes from the clinical trials and government approved SAS’s use of NanaBis drug
March 14, 2019 12:28 AM AEDT| By Team Kalkine MediaMedlab Clinical Limited (ASX: MDC) is a medical research and development company based in Australia. It is researching and formulating novel bio-therapeutic drugs for treatment of early to moderate stage chronic diseases. According to the National C...
ResApp Health Received Green Light from AusIndustry for R&D Advanced Overseas Finding
March 13, 2019 08:44 PM AEDT| By Team Kalkine MediaThe developer of digital healthcare solutions, ResApp Health Limited (ASX: RAP) has notified the market that it had obtained approval from AusIndustry regarding its application, for an Advanced/Overseas Finding in connection with clinical study expen...
Paradigm Biopharmaceuticals published Investor Presentation: Stock surged over 9%
March 13, 2019 04:04 PM AEDT| By Team Kalkine MediaASX listed, a biotechnology company, Paradigm Biopharmaceuticals Limited (ASX: PAR) has published its investor presentation. PAR is engaged in developing ethically safe drug for the treatment of musculoskeletal disorders in human. The company is cur...
Sigma Healthcare Provides An Update On API Proposal
March 13, 2019 02:15 PM AEDT| By Team Kalkine MediaThe Board of Sigma Healthcare Limited (ASX: SIG) believes that the current API proposal is not reflecting the long-term prospects and value inherent in Sigma, which is why the Board has concluded that the current API proposal is not in the best inter...
Ellex Medical’s Shares Uplifted On ASX After Announcing The Results Of Its LiGHT’s Clinical Trial
March 12, 2019 06:47 PM AEDT| By Team Kalkine MediaLeading medical technology company, Ellex Medical Lasers Limited (ASX: ELX) have announced the results of Laser in Glaucoma and Ocular HyperTension (LiGHT) clinical trial which demonstrated that selective laser trabeculoplasty (SLT) is safe and effec...
Cynata to go Ahead with their Phase 2 Clinical Trial Post Favourable Advice from MHRA
March 12, 2019 04:58 PM AEDT| By Team Kalkine MediaCynata Therapeutics (ASX: CYP) is an Australian biotechnology company which is in the business of researching and manufacturing regenerative medicine targeted towards the development of therapies based on a proprietary therapeutic stem cell platform...
Advertise your brand on Kalkine Media